Gold prices dip as hawkish Fed minutes weigh ahead of Jackson Hole
Concord Medical (TASE:BLWV) Services Holdings Limited (NYSE:CCM), a healthcare provider specializing in cancer and other medical treatments, announced on Wednesday that its controlling shareholder, Medstar (Shanghai) Enterprise Management Co., LTD ("Shanghai Medstar"), has increased its shareholding in the company. Shanghai Medstar, a subsidiary of Concord Medical, purchased 45,600 H shares of Concord Healthcare Group Co., Ltd. on the Hong Kong Stock Exchange (HKSE), representing approximately 0.01% of the total issued shares.
This transaction, which took place on May 7, 2025, is seen as a sign of confidence by the controlling shareholder in Concord Medical’s continuous development. The shares were acquired from the open market, according to the company’s statement.
Concord Medical had previously announced the listing of Concord Healthcare’s H shares on the HKSE on January 9, 2024. Information regarding Concord Healthcare’s transactions can be found on the HKSE’s website.
The purchase by Shanghai Medstar reflects ongoing support for Concord Medical’s operations and business strategy. The company, headquartered in Beijing, operates a network of radiotherapy and diagnostic imaging centers in China and is known for its advanced cancer treatment facilities.
This news was reported in accordance with the Securities Exchange Act of 1934 and was officially filed with the United States Securities and Exchange Commission. The report was signed by Jianyu Yang, Chairman and Chief Executive Officer of Concord Medical Services Holdings Limited, and is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.